Stockreport

Novocure on go to start late-stage study of Optune in pancreatic cancer; shares up 3% [Seeking Alpha]

NovoCure Limited - Ordinary Shares  (NVCR) 
Last novocure limited - ordinary shares earnings: 4/30 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: novocure.com/investor-relations
PDF Novocure on go to start late-stage study of Optune in pancreatic cancer; shares up 3%The FDA hassigned off on a Phase 3 clinical trial, PANOVA 3, assessing Novocure's (N [Read more]